DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Antivert (Meclizine HCl) - Indications and Dosage

 
 



INDICATIONS

Based on a review of this drug by the National Academy of Sciences - National Research Council and/or other information, FDA has classified the indications as follows:

Effective: Management of nausea and vomiting, and dizziness associated with motion sickness.

Possibly Effective: Management of vertigo associated with diseases affecting the vestibular system.

Final classification of the less than effective indications requires further investigation.

DOSAGE AND ADMINISTRATION

Vertigo:

For the control of vertigo associated with diseases affecting the vestibular system, the recommended dose is 25 to 100 mg daily, in divided dosage, depending upon clinical response.

Motion Sickness:

The initial dose of 25 to 50 mg of Antivert should be taken one hour prior to embarkation for protection against motion sickness. Thereafter, the dose may be repeated every 24 hours for the duration of the journey.

HOW SUPPLIED

Antivert®—12.5 mg tablets:

Bottles of 100 (NDC 0662-2100-66), (NDC 0049-2100-66)

Bottles of 1000 (NDC 0662-2100-82), (NDC 0049-2100-82)

Antivert®/25--25 mg tablets:

Bottles of 100 (NDC 0662-2110-66), (NDC 0049-2110-66)

Bottles of 1000 (NDC 0662-2110-82), (NDC 0049-2110-82)

Antivert®/50—50 mg tablets: Bottles of 100 (NDC 0662-2140-66), (NDC 0049-2140-66)

1996 PFIZER INC

Revised June 1996

Roerig - Division of Pfizer Inc, NY, NY 10017

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017